Browse by ORCID

Journal article

PEARSON, J.R.D., PUIG-SAENZ, C., THOMAS, J.E., HARDOWAR, L.D., AHMAD, M., WAINWRIGHT, L.C., MCVICAR, A.M., BRENTVILLE, V.A., TINSLEY, C.J., POCKLEY, A.G., DURRANT, L.G. and MCARDLE, S.E.B., 2024. TRP-2 / gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumors. Cancer Immunology, Immunotherapy, 73 (9): 178. ISSN 0340-7004

SAIF, J.M.S., VADAKEKOLATHU, J., RANE, S.S., MCDONALD, D., AHMAD, M., MATHIEU, M., POCKLEY, A.G., DURRANT, L., METHERINGHAM, R., REES, R.C. and MCARDLE, S.E.B., 2014. Novel prostate acid phosphatase-based peptide vaccination strategy induces antigen-specific T-cell responses and limits tumour growth in mice. European Journal of Immunology, 44 (4), pp. 994-1004. ISSN 0014-2980

MATHIEU, M.G., MILES, A.K., AHMAD, M., BUCZEK, M.E., POCKLEY, A.G., REES, R.C. and REGAD, T., 2014. The helicase HAGE prevents interferon-a-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1. Cell Death and Disease, 5 (2). ISSN 2041-4889

VAFADAR-ISFAHANI, B., LAVERSIN, S.A., AHMAD, M., BALL, G., COVENEY, C., LEMETRE, C., MILES, A.K., VAN SCHALKWYK, G., REES, R.C. and MATHAROO-BALL, B., 2010. Serum biomarkers which correlate with failure to respond to immunotherapy and tumor progression in a murine colorectal cancer model. Proteomics Clinical Applications, 4 (89), pp. 682-696. ISSN 1862-8346

ZHANG, W., CASPELL, R., KARULIN, A.Y., AHMAD, M., HAICHEUR, N., ABDELSALAM, A., JOHANNESEN, K., VIGNARD, V., DUDZIK, P., GEORGAKOPOULOU, K., MIHAYLOVA, A., SILINA, K., APTSIAURI, N., ADAMS, V., LEHMANN, P.V. and MCARDLE, S., 2009. ELISPOT assays provide reproducible results among different laboratories for T-cell immune monitoring -- even in hands of ELISPOT-inexperienced investigators. Journal of Immunotoxicology, 6 (4), pp. 227-234. ISSN 1547-691X

ASSUDANI, D.P., AHMAD, M., LI, G., REES, R.C. and ALI, S.A., 2006. Immunotherapeutic potential of DISC-HSV and OX40L in cancer. Cancer Immunology Immunotherapy, 55 (1), pp. 104-111. ISSN 0340-7004

ASSUDANI, D.P., AHMAD, M., LI, G., REES, R.C. and ALI, S.A., 2006. Immunotherapeutical potential of DISC-HSV and OX40L in cancer. Cancer Immunology, Immunotherapy, 55 (1), pp. 104-111. ISSN 0340-7004

MILES, A.K., MATHAROO-BALL, B., LI, G., AHMAD, M. and REES, R.C., 2006. The identification of human tumour antigens: current status and future developments. Cancer Immunology Immunotherapy, 55 (8), pp. 996-1003. ISSN 0340-7004

LI, G., ALI, S.A., MCARDLE, S.E., MIAN, S., AHMAD, M., MILES, A. and REES, R.C., 2005. Immunity to tumour antigens. Current Pharmaceutical Design, 11 (27), pp. 3501-3509. ISSN 1381-6128

AHMAD, M., REES, R.C., MCARDLE, S.E., LI, G., MIAN, S., ENTWISLE, C., LOUDON, P. and ALI, S.A., 2005. Regulation of CTL responses to MHC-restricted class I peptide of the gp70 tumour antigen by splenic parenchymal CD4(+) T cells in mice failing immunotherapy with DISC-mGM-CSF. International Journal of Cancer, 115 (6), pp. 951-959. ISSN 0020-7136

ALI, S.A., AHMAD, M., LYNAM, J., MCLEAN, C.S., ENTWISLE, C., LOUDON, P., CHOOLUN, E., MCARDLE, S.E., LI, G., MIAN, S. and REES, R.C., 2004. Anti-tumour therapeutic efficacy of OX40L in murine tumour model. Vaccine, 22 (2728), pp. 3585-3594. ISSN 0264-410X

AHMAD, M., REES, R.C. and ALI, S.A., 2004. Escape from immunotherapy: possible mechanisms that influence tumor regression/progression. Cancer Immunology, Immunotherapy, 53 (10), pp. 844-854. ISSN 0340-7004

ALI, S., AHMAD, M., LYNAM, J., REES, R.C. and BROWN, N., 2004. Trafficking of tumor peptide-specific cytotoxic T lymphocytes into the tumor microcirculation. International Journal of Cancer, 110 (2), pp. 239-244. ISSN 0020-7136

REES, R.C., MCARDLE, S.E., MIAN, S., LI, G., AHMAD, M., PARKINSON, R. and ALI, S.A., 2002. Disabled infectious single cycle-herpes simplex virus (DISC-HSV) as a vector for immunogene therapy of cancer. Current Opinion in Molecular Therapeutics, 4 (1), pp. 49-53. ISSN 1464-8431

Chapter in book

ASSUDANI, D.P., MCARDLE, S.E., AHMAD, M., LI, G., REES, R.C. and ALI, S.A., 2008. Vaccination strategies for malignant diseases. In: Treatment of cancer. Hodder Arnold, p. 167.

Conference contribution

ASSUDANI, D.P., AHMAD, M., LI, G., REES, R.C. and ALI, S.A., 2004. Immunotherapeutical potential of DISC-HSV and OX40L in cancer. In: Conference on Progress in Vaccination Against Cancer, Frendenstadt Lauterbad, Germany, 22-25 September 2004, Frendenstadt Lauterbad, Germany.

Thesis

AHMAD, M., 2004. Mechanisms of tumour escape following intratumour therapy with DISC-HSV in murine model. PhD, Nottingham Trent University.